Skin cancer evaluation in transplant patients: a physician opinion survey with recommendations

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Clinical Transplantation

• Publication date

  2015-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/ctr.12490PMID 25530232
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Two-year randomized controlled prospective trial converting treatment of stable renal transplant recipients with cutaneous invasive squamous cell carcinomas to sirolimus.

  2013cited by this paper
• Psoriasis, cardiovascular events, cancer risk and alcohol use: evidence‐based recommendations based on systematic review and expert opinion

  2013cited by this paper
• A randomised, double-blind, controlled trial comparing two intra-articular hyaluronic acid preparations differing by their molecular weight in symptomatic knee osteoarthritis

  2012cited by this paper
• Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease.

  2012cited by this paper
• Sirolimus and secondary skin-cancer prevention in kidney transplantation.

  2012cited by this paper
• Conversion to sirolimus in kidney transplant recipients with squamous cell cancer and changes in immune phenotype

  2012cited by this paper
• Combined introduction of anti-IL2 receptor antibodies, mycophenolic acid and tacrolimus: effect on malignancies after renal transplantation in a single-centre retrospective cohort study.

  2012cited by this paper
• Management of Non-Melanoma Skin Cancer in Immunocompromised Solid Organ Transplant Recipients

  2012cited by this paper
• Therapeutic Options to Decrease Actinic Keratosis and Squamous Cell Carcinoma Incidence and Progression in Solid Organ Transplant Recipients: A Practical Approach

  2012cited by this paper
• Reversal of UVA Skin Photosensitivity and DNA Damage in Kidney Transplant Recipients by Replacing Azathioprine

  2012cited by this paper
• Management of Skin Cancer in Solid-organ Transplant Recipients: A Multidisciplinary Approach.

  2011cited by this paper
• Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease.

  2011cited by this paper
• Skin cancer in solid organ transplant recipients: advances in therapy and management: part II. Management of skin cancer in solid organ transplant recipients.

  2011cited by this paper
• Skin cancer in solid organ transplant recipients: advances in therapy and management: part I. Epidemiology of skin cancer in solid organ transplant recipients.

  2011influential reference
• Skin Cancer in Transplant Recipients, Out of the Woods. Scientific Retreat of the ITSCC and SCOPE

  2011cited by this paper
• Lower Malignancy Rates in Renal Allograft Recipients Converted to Sirolimus-Based, Calcineurin Inhibitor-Free Immunotherapy: 24-Month Results From the CONVERT Trial

  2011cited by this paper
• Cancer risk with tumor necrosis factor alpha (TNF) inhibitors: meta‐analysis of randomized controlled trials of adalimumab, etanercept, and infliximab using patient level data

  2011cited by this paper
• Cyclosporine A suppresses keratinocyte cell death through MPTP inhibition in a model for skin cancer in organ transplant recipients.

  2010cited by this paper
• Calcineurin and ATF3: opposite roles in squamous skin cancer

  2010cited by this paper
• Comparison of the Incidence of Malignancy in Recipients of Different Types of Organ: A UK Registry Audit

  2010cited by this paper
• Switch to a Sirolimus‐Based Immunosuppression in Long‐Term Renal Transplant Recipients: Reduced Rate of (Pre‐)Malignancies and Nonmelanoma Skin Cancer in a Prospective, Randomized, Assessor‐Blinded, Controlled Clinical Trial

  2010cited by this paper
• Prevention of non‐melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case–control study

  2009cited by this paper
• De novo post-transplantation malignancies: incidence and risk factors.

  2009cited by this paper
• Solid cancers after allogeneic hematopoietic cell transplantation.

  2009cited by this paper
• Skin Cancer in Organ Transplant Recipients—Where Do We Stand Today?

  2008cited by this paper
• Topical photodynamic therapy of actinic keratosis in renal transplant recipients.

  2007cited by this paper
• Treatment of post‐transplant premalignant skin disease: a randomized intrapatient comparative study of 5‐fluorouracil cream and topical photodynamic therapy

  2007cited by this paper
• Immunosuppression and squamous cell carcinoma: a focus on solid organ transplant recipients.

  2007cited by this paper
• Reduction of immunosuppression for transplant‐associated skin cancer: thresholds and risks

  2007influential reference
• Mycophenolate mofetil and risk of developing malignancy after orthotopic heart transplantation: analysis of the transplant registry of the International Society for Heart and Lung Transplantation.

  2006cited by this paper
• Successful treatment of multiple actinic keratoses in organ transplant patients with topical 5% imiquimod: a report of six cases

  2006cited by this paper
• Specialist dermatology clinics for organ transplant recipients significantly improve compliance with photoprotection and levels of skin cancer awareness

  2006cited by this paper
• Reduction of immunosuppression for transplant‐associated skin cancer: expert consensus survey

  2006influential reference
• Nonmelanoma skin and mucosal cancers after hematopoietic cell transplantation.

  2006cited by this paper
• Baseline Quality of Life and Anxiety in Solid Organ Transplant Recipients: A Pilot Study

  2006cited by this paper
• Educational outcomes regarding skin cancer in organ transplant recipients: Randomized intervention of intensive vs standard education.

  2006cited by this paper
• Mortality and clinicopathological features of cutaneous squamous cell carcinoma in organ transplant recipients: a study of the Swedish cohort.

  2006cited by this paper
• Survival signaling by Notch1: mammalian target of rapamycin (mTOR)-dependent inhibition of p53.

  2006cited by this paper
• Special concern about squamous cell carcinoma of the scalp in organ transplant recipients.

  2006cited by this paper
• Reduction of Immunosuppression for Transplant‐Associated Skin Cancer: Rationale and Evidence of Efficacy

  2005cited by this paper
• Low-dose retinoids in the prevention of cutaneous squamous cell carcinomas in organ transplant recipients: a 16-year retrospective study.

  2005cited by this paper
• Safety and efficacy of 5% imiquimod cream for the treatment of skin dysplasia in high-risk renal transplant recipients: randomized, double-blind, placebo-controlled trial.

  2005cited by this paper
• Skin cancer, rheumatoid arthritis, and tumor necrosis factor inhibitors.

  2005cited by this paper
• The impact of skin disease following renal transplantation on quality of life

  2005cited by this paper
• Azathioprine and UVA Light Generate Mutagenic Oxidative DNA Damage

  2005cited by this paper
• Management of skin cancer in solid organ transplant recipients

  2005cited by this paper
• Renal-Transplant Recipients and Sun Protection

  2004cited by this paper
• Specialty Clinics for the Dermatologic Care of Solid‐Organ Transplant Recipients

  2004cited by this paper
• Histologic Features in Primary Cutaneous Squamous Cell Carcinomas in Immunocompromised Patients Focusing on Organ Transplant Patients

  2004cited by this paper
• Tumor necrosis factor-alpha blockade for the treatment of acute GVHD.

  2004cited by this paper
• Guidelines for the Management of Squamous Cell Carcinoma in Organ Transplant Recipients

  2004cited by this paper
• Defining the clinical course of metastatic skin cancer in organ transplant recipients: a multicenter collaborative study.

  2003cited by this paper
• Skin cancers after organ transplantation.

  2003cited by this paper
• Skin cancers after organ transplantation.

  2003cited by this paper
• Skin cancer in organ transplant recipients: Epidemiology, pathogenesis, and management.

  2002cited by this paper
• Recombinant human tumor necrosis factor receptor fusion protein as complementary treatment for chronic graft-versus-host disease.

  2002cited by this paper
• Acitretin for chemoprevention of non‐melanoma skin cancers in renal transplant recipients

  2002cited by this paper
• General health management and long-term care of the renal transplant recipient.

  2001cited by this paper
• Post-Transplant Malignancy

  2000cited by this paper
• Organization of a specialty clinic to optimize the care of organ transplant recipients at risk for skin cancer.

  2000cited by this paper
• Incidence of skin cancer in 5356 patients following organ transplantation

  2000cited by this paper
• Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation.

  2000cited by this paper
• Skin cancer in Australian heart transplant recipients.

  1999cited by this paper
• Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens.

  1999cited by this paper
• Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens.

  1999cited by this paper
• Awareness of skin cancer by kidney transplant patients.

  1999cited by this paper
• Aggressive cutaneous malignancies following cardiothoracic transplantation

  1999influential reference
• Skin cancer chemoprophylaxis in renal transplant recipients: 5 years of experience using low‐dose acitretin

  1999cited by this paper
• High incidence and clinical course of aggressive skin cancer in heart transplant patients: a single-center study.

  1998influential reference
• Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA Follow-up Study.

  1998cited by this paper
• Solid cancers after bone marrow transplantation.

  1997cited by this paper
• Retinoids for the Management of Dermatological Complications of Organ Transplantation

  1997cited by this paper
• Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study.

  1995cited by this paper
• De novo malignancy emerges as a major cause of morbidity and late failure in renal transplantation.

  1993cited by this paper
• The changing pattern of posttransplant malignancies.

  1991cited by this paper
• Incidence of skin cancer after renal transplantation in The Netherlands.

  1990cited by this paper
• EFFECTS OF IMMUNOSUPPRESSIVE THERAPY ON THE INDUCTION OF SKIN TUMORS BY ULTRAVIOLET IRRADIATION IN HAIRLESS MICE

  1987cited by this paper
• Oral methoxsalen photochemotherapy of mycosis fungoides

  1976cited by this paper
• The Netherlands Source: Cbs/cheps Higher Education Monitor

  year unknowncited by this paper

• Incidence and risk factors for skin cancer in liver transplant recipients: A systematic review.

  2025cites this paper
• Immunosuppression regimen and latitude impact keratinocyte carcinoma risk in U.S. liver transplant recipients

  2024cites this paper
• Skin cancer screening in organ transplant centres in the United Kingdom: a national survey

  2020cites this paper
• Melanoma incidence, stage, and survival after solid organ transplant: A population-based cohort study in Ontario, Canada.

  2020cites this paper
• Cutaneous Squamous Cell Carcinoma in Solid Organ Transplant Patients

  2020cites this paper
• Initial skin cancer screening for solid organ transplant recipients in the United States: Delphi method development of expert consensus guidelines

  2019cites this paper
• Skin cancer screening after solid organ transplantation: Survey of practices in Canada

  2019cites this paper
• Skin Cancer Following Solid Organ Transplantation: A Review of Risk Factors and Models of Care

  2018cites this paper
• Improved keratinocyte carcinoma outcomes with annual dermatology assessment after solid organ transplantation: Population‐based cohort study

  2018cites this paper
• Keratinocyte Carcinomas: Current Concepts and Future Research Priorities

  2018cites this paper
• Low Rates of Dermatologic Care and Skin Cancer Screening Among Inflammatory Bowel Disease Patients

  2018cites this paper
• Comparison of pre‐ and post‐transplant sun‐safe behavior of kidney transplant recipients: What is needed to improve?

  2018cites this paper
• Lycopene Protects Keratinocytes Against UVB Radiation‐Induced Carcinogenesis via Negative Regulation of FOXO3a Through the mTORC2/AKT Signaling Pathway

  2018cites this paper
• USING REAL-WOLRD HEALTHCARE DATA TO DEFINE AND PREVENT COMPLICATIONS IN INFLAMMATORY BOWEL DISEASE

  2017cites this paper
• Comprehensive Care of the Lung Transplant Patient

  2017cites this paper
• Title: Epithelial Skin cancers after kidney transplantation: a retrospective single-centre study on 376 recipients Short title: Non melanoma skin cancer in renal transplant recipients

  2017cites this paper
• Inflammatory nephrocutaneous diseases including associated cutaneous and renal manifestations and referral considerations Disease Cutaneous findings Renal findings

  2016cites this paper
• The spectrum of nephrocutaneous diseases and associations: Inflammatory and medication-related nephrocutaneous associations.

  2016cites this paper
• 2015 Publications of the Baylor Scott & White Health North Division Medical and Scientific Staff

  2016cites this paper
• The spectrum of nephrocutaneous diseases and associations: Genetic causes of nephrocutaneous disease.

  2016cites this paper
• [Treatment options of non-melanoma skin tumors in organ transplant recipients in relation to a case report].

  2016cites this paper
• Epithelial skin cancers after kidney transplantation: a retrospective single-centre study of 376 recipients

  2016cites this paper
• Cutaneous Squamous Cell Carcinomas in Organ Transplant Recipients

  2015cites this paper